Spyre Therapeutics, Inc.

DEUTSCHE BANK AG\ SYRE

Report date

3/31/2022

Quarter

2022 Q1

Filed

5/13/2022

Shares

515,133

Value ($000)

1,185

Weight

0.0%

2018 Q2 - 2022 Q1 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q1	5/13/2022	1,185	0.0%	515,133	3/31/2022
2021 Q4	2/16/2022	117	0.0%	24,535	12/31/2021
2021 Q3	11/4/2021	185	0.0%	23,243	9/30/2021
2021 Q2	8/11/2021	167	0.0%	23,993	6/30/2021
2021 Q1	5/13/2021	243	0.0%	30,718	3/31/2021
2020 Q4	2/16/2021	263	0.0%	33,463	12/31/2020
2020 Q3	11/12/2020	465	0.0%	65,559	9/30/2020
2020 Q2	8/13/2020	588	0.0%	63,523	6/30/2020
2020 Q1	5/14/2020	238	0.0%	51,003	3/31/2020
2019 Q4	2/14/2020	486	0.0%	63,769	12/31/2019
2018 Q3	12/21/2021	356	—	37,219	9/30/2018
2018 Q2	4/21/2020	1,962	—	185,494	6/30/2018